ANITA DESWAL to Myocarditis
This is a "connection" page, showing publications ANITA DESWAL has written about Myocarditis.
Connection Strength
2.920
-
COVID-19-Associated Fulminant?Myocarditis: Pathophysiology-Related Phenotypic Variance. J Am Coll Cardiol. 2022 07 26; 80(4):313-315.
Score: 0.670
-
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc. 2020 01 21; 9(2):e013757.
Score: 0.563
-
Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis. Cancer Immunol Res. 2024 08 01; 12(8):964-987.
Score: 0.193
-
Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis. J Nucl Cardiol. 2024 Sep; 39:101909.
Score: 0.192
-
Cardiovascular toxicity of immune therapies for cancer. BMJ. 2024 05 15; 385:e075859.
Score: 0.190
-
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. Eur J Cancer. 2022 12; 177:197-205.
Score: 0.168
-
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis. Arch Cardiovasc Dis. 2022 May; 115(5):315-330.
Score: 0.165
-
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review. JAMA Cardiol. 2021 11 01; 6(11):1329-1337.
Score: 0.159
-
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation. 2021 11 02; 144(18):1521-1523.
Score: 0.159
-
Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail. 2021 10; 23(10):1725-1735.
Score: 0.155
-
Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors. Arthritis Rheumatol. 2021 05; 73(5):866-874.
Score: 0.153
-
COVID-19 myocarditis and long-term heart failure sequelae. Curr Opin Cardiol. 2021 03 01; 36(2):234-240.
Score: 0.152